يعرض 261 - 280 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significance ((step decrease) OR (teer decrease)) ))', وقت الاستعلام: 0.49s تنقيح النتائج
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266

    Cesarean section. حسب Eva Rydahl (6260771)

    منشور في 2025
    الموضوعات:
  7. 267

    Flow chart of study participants. حسب Eva Rydahl (6260771)

    منشور في 2025
    الموضوعات:
  8. 268
  9. 269

    Absolute numbers among CS groups. حسب Eva Rydahl (6260771)

    منشور في 2025
    الموضوعات:
  10. 270
  11. 271
  12. 272
  13. 273

    Patient Example. حسب James M. Friedman (22522150)

    منشور في 2025
    الموضوعات:
  14. 274
  15. 275
  16. 276

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  17. 277
  18. 278
  19. 279

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  20. 280

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"